| abstract |
The present invention relates to compounds of the formulae: Formula (I), (II), (III), (IV), (V), (VI) in which R is C 5 -C 16 alkyl, R 1 is Formula (VII), or Formula (VIII) and isosteres and saltes therof. These compounds are serine protease procarboxypeptidase (FRCP) inhibitors and can be used in the field of weight management and in the preparation of medications for the treatment and management of obesity. Further, the present invention relates to new anorexigenic and anti-inflammatory drugs, acting through PRCP-mediated mechanisms. |